(DHR)

Role: EVP & Chief Financial Officer
Signature: /s/ James F. O'Reilly, attorney-in-fact for Matthew McGrew
Issuer symbol: DHR
Transactions as of: 04 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Feb 2026, 17:00:53 UTC
Previous filing: 04 Feb 2026
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
McGrew Matthew	EVP & Chief Financial Officer	2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON	/s/ James F. O'Reilly, attorney-in-fact for Matthew McGrew	06 Feb 2026	0001754423

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DHR	Common Stock	Award	$0	+2,684	+15%	$0.000000	20,890	04 Feb 2026	Direct	F1
holding	DHR	Common Stock						10,233	04 Feb 2026	By 401(k)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 24, 2023, the Compensation Committee of the Company's Board of Directors awarded the reporting person performance stock units under the Danaher Corporation 2007 Omnibus Incentive Plan. This Form 4 is being filed in connection with the determination by the Compensation Committee that the performance criteria of the award have been achieved. The award remains subject to a holding period that continues through December 31, 2027.

Content

On February 24, 2023, the Compensation Committee of the Company's Board of Directors awarded the reporting person performance stock units under the Danaher Corporation 2007 Omnibus Incentive Plan. This Form 4 is being filed in connection with the determination by the Compensation Committee that the performance criteria of the award have been achieved. The award remains subject to a holding period that continues through December 31, 2027.